Gelteq Limited Ordinary Shares (GELS) vs Imunon, Inc. (IMNN)

A side-by-side comparison of Gelteq Limited Ordinary Shares and Imunon, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Gelteq Limited Ordinary Shares logo
GELS
Gelteq Limited Ordinary Shares
$5M
$0.55HealthcareDelayed quote: Oct 6, 2026, 10:39 AM EDT
Imunon, Inc. logo
IMNN
Imunon, Inc.
$5M
$1.22HealthcareDelayed quote: Oct 6, 2026, 10:39 AM EDT

Total return — GELS vs IMNN

growth of $100 · dividends reinvested · last 2y
GELS -81.5% (-57.0%/yr)IMNN -91.5% (-70.8%/yr)GELS compounded faster over this window
050100150200250Start $10020252026$18$9
GELS IMNN

GELS vs IMNN: by the numbers

  • •IMNN is the larger company ($5M vs $5M market cap).
  • •Both run net losses; IMNN's is the smaller (0.00% vs -4011.86% net margin).

Metrics side by side

Valuation

MetricGELSIMNN
P/B ratio0.541.22

Profitability

MetricGELSIMNN
Gross margin100.00%0.00%
Operating margin-3317.65%0.00%
Net margin-4011.86%0.00%
ROE-42.05%-351.30%
ROIC-27.41%-126.69%

Growth (annualized)

MetricGELSIMNN
Total return CAGR (5Y)N/A-63.83%

Go deeper

Full GELS analysisFull IMNN analysisInteractive comparison tool

Dig into the metrics

Gelteq Limited Ordinary Shares ROEImunon ROEGelteq Limited Ordinary Shares operating marginImunon operating marginGelteq Limited Ordinary Shares revenue growthImunon revenue growthGelteq Limited Ordinary Shares free cash flowImunon free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.